110 related articles for article (PubMed ID: 31127759)
1. Serum inducible protein-10 chemokine as a biomarker for clearance of HCV with and without treatment in Egyptian patients.
Tabll A; El Shenawy R; Elsharkawy H; Mohamed FZ
Hum Antibodies; 2019; 27(4):265-273. PubMed ID: 31127759
[TBL] [Abstract][Full Text] [Related]
2. CXCL9 chemokine level is associated with spontaneous clearance and sustained virological response in Egyptian Chronic Hepatitis C patients receiving direct acting antivirals.
Tabll AA; Afifi MS; El-Etrawy AS; El-Kousy SM; Smolic M; El Abd YS
Hum Antibodies; 2020; 28(2):141-148. PubMed ID: 32675406
[TBL] [Abstract][Full Text] [Related]
3. Relationship of interferon-γ-inducible protein-10 kDa with viral response in patients with various heterogeneities of hepatitis C virus genotype-4.
Al-Ashgar HI; Khan MQ; Helmy A; Al-Thawadi S; Al-Ahdal MN; Khalaf N; Al-Qahtani A; Sanai FM
Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):404-10. PubMed ID: 23470264
[TBL] [Abstract][Full Text] [Related]
4. Interferon-γ-inducible protein-10 in chronic hepatitis C: Correlations with insulin resistance, histological features & sustained virological response.
Crisan D; Grigorescu MD; Radu C; Suciu A; Grigorescu M
Indian J Med Res; 2017 Apr; 145(4):543-550. PubMed ID: 28862188
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment serum interferon gamma inducible protein-10 as biomarker of fibrosis and predictor of virological response in genotype 4 hepatitis C virus infection.
Khalifa KA; Radwan WM; Attallah KM; Hosney H; Eed EM
Acta Gastroenterol Belg; 2014 Dec; 77(4):401-7. PubMed ID: 25682629
[TBL] [Abstract][Full Text] [Related]
6. Association of interferon-γ-induced protein-10 serum levels with virological responses to PEG-interferon-based therapy in hepatitis C virus genotype 1 or 2 chronically infected Chinese patients.
Wang J; Jiang D; Rao H; Yang R; Wang Y; Wei L
Scand J Gastroenterol; 2014 Nov; 49(11):1349-58. PubMed ID: 25263691
[TBL] [Abstract][Full Text] [Related]
7. IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C.
Fattovich G; Covolo L; Bibert S; Askarieh G; Lagging M; Clément S; Malerba G; Pasino M; Guido M; Puoti M; Gaeta GB; Santantonio T; Raimondo G; Bruno R; Bochud PY; Donato F; Negro F;
Aliment Pharmacol Ther; 2011 May; 33(10):1162-72. PubMed ID: 21443535
[TBL] [Abstract][Full Text] [Related]
8. IP-10 Serum Level in Chronic Hepatitis C Virus Patients: Relation to Fibrosis and Response to Combined Interferon/Ribavirin Therapy.
El Raziky M; Elsharkawy A; Said SE; Abdelatty S; El Akel W; Tantawy O; Gamal Eldeen H; Mabrouk M
J Interferon Cytokine Res; 2015 Aug; 35(8):649-53. PubMed ID: 25973761
[TBL] [Abstract][Full Text] [Related]
9. Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection.
Beinhardt S; Aberle JH; Strasser M; Dulic-Lakovic E; Maieron A; Kreil A; Rutter K; Staettermayer AF; Datz C; Scherzer TM; Strassl R; Bischof M; Stauber R; Bodlaj G; Laferl H; Holzmann H; Steindl-Munda P; Ferenci P; Hofer H
Gastroenterology; 2012 Jan; 142(1):78-85.e2. PubMed ID: 22192885
[TBL] [Abstract][Full Text] [Related]
10. IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection.
Reiberger T; Aberle JH; Kundi M; Kohrgruber N; Rieger A; Gangl A; Holzmann H; Peck-Radosavljevic M
Antivir Ther; 2008; 13(8):969-76. PubMed ID: 19195322
[TBL] [Abstract][Full Text] [Related]
11. Association of interferon-γ inducible protein-10 pretreatment level and sustained virological response in HCV-positive Egyptian patients.
Omran D; Hamdy S; Tawfik S; Esmat S; Saleh DA; Zayed RA
Ann Clin Lab Sci; 2014; 44(2):167-72. PubMed ID: 24795055
[TBL] [Abstract][Full Text] [Related]
12. IL28B and interferon-gamma inducible protein 10 for prediction of rapid virologic response and sustained virologic response in HIV-HCV-coinfected patients.
Payer BA; Reiberger T; Aberle J; Ferenci P; Holzmann H; Rieger A; Peck-Radosavljevic M;
Eur J Clin Invest; 2012 Jun; 42(6):599-606. PubMed ID: 22117591
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients.
Derbala M; Rizk NM; Al-Kaabi S; John A; Sharma M; El-dweik N; Yakoob R; Pasic F; Almohanadi M; Alejji K; Abdelmola A; Butt M
Virology; 2013 Sep; 444(1-2):292-300. PubMed ID: 23866096
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment predictive factors for hepatitis C therapy outcome: relevance of anti-E1E2 antibodies compared to IP-10 and IL28B genotypes.
Arnaud C; Pradat P; Spaziante M; Berthillon P; Maynard M; Taliani G; Chemin I; Trépo C; Petit MA
Antivir Ther; 2013; 18(8):1027-32. PubMed ID: 23948510
[TBL] [Abstract][Full Text] [Related]
15. Role of HCV-RNA decay and IP-10 levels after 48 hours of standard HCV therapy as predictors of rapid virological response.
Prinapori R; Sticchi L; Alicino C; Del Puente F; Mazzarello G; Alessandrini A; Signori A; Icardi G; Bruzzone B; Viscoli C; Di Biagio A
Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):705-10. PubMed ID: 26070571
[TBL] [Abstract][Full Text] [Related]
16. Ultrasensitive HCV RNA Quantification in Antiviral Triple Therapy: New Insight on Viral Clearance Dynamics and Treatment Outcome Predictors.
Garbuglia AR; Visco-Comandini U; Lionetti R; Lapa D; Castiglione F; D'Offizi G; Taibi C; Montalbano M; Capobianchi MR; Paci P
PLoS One; 2016; 11(8):e0158989. PubMed ID: 27560794
[TBL] [Abstract][Full Text] [Related]
17. Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C.
Diago M; Castellano G; García-Samaniego J; Pérez C; Fernández I; Romero M; Iacono OL; García-Monzón C
Gut; 2006 Mar; 55(3):374-9. PubMed ID: 16150856
[TBL] [Abstract][Full Text] [Related]
18. Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection.
Romero AI; Lagging M; Westin J; Dhillon AP; Dustin LB; Pawlotsky JM; Neumann AU; Ferrari C; Missale G; Haagmans BL; Schalm SW; Zeuzem S; Negro F; Verheij-Hart E; Hellstrand K;
J Infect Dis; 2006 Oct; 194(7):895-903. PubMed ID: 16960776
[TBL] [Abstract][Full Text] [Related]
19. Changes in the co-expressions of interleukin 29 (IL-29), IFN-inducible protein 10 (IP-10) and monokine induced by IFNγ (MIG) genes in chronic hepatitis C Egyptian patients untreated and treated with DAAs.
Gaballah A; Naga IS; Zaghloul MS; Mostafa HM; Noby A
Acta Virol; 2021; 65(2):141-148. PubMed ID: 34130465
[TBL] [Abstract][Full Text] [Related]
20. Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy.
Meissner EG; Decalf J; Casrouge A; Masur H; Kottilil S; Albert ML; Duffy D
PLoS One; 2015; 10(7):e0133236. PubMed ID: 26181438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
